“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

A new era in transplantation is here. Roswell Park reports a remarkable 92.6% one-year survival rate following allogeneic transplant—well above the national average—thanks to evidence-based innovations transforming patient care.

July 8, 2026

Roswell Park Comprehensive Cancer Center

Objective:

To report improved one-year survival rates following allogeneic hematopoietic cell transplantation at Roswell Park Comprehensive Cancer Center.

Approach:

Prophylactic Treatment: Implemented prophylactic treatment to protect against graft-versus-host disease.
Operational Changes: Reduced antibiotic and IV use, and made program-wide operational and patient care adjustments based on clinical evidence.
Patient Selection: Expanded eligibility for transplantation to include liquid tumor patients up to age 85 and non-perfect match donors.
Evidence-Based Practices: Adopted new practices including reduced IV fluids and antibiotics, increased exercise, and early discharge for eligible patients.

Key Findings:

Achieved a 92.6% one-year survival rate post-transplant, surpassing the national average of approximately 80%.
Operational consistency and deliberate donor selection strategies improved patient outcomes.
Streamlined procedures reduced drug costs by about half.

Interpretation:

The findings indicate a significant advancement in transplant outcomes due to evidence-based operational changes and patient care strategies.

Limitations:

The study reflects outcomes from a single center and may not be generalizable to all transplant centers.

Conclusion:

The changes implemented at Roswell Park aim to improve accessibility and outcomes for a broader patient population.

Sources:

Transplantation and Cellular Therapy Journal

“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

Objective:

Approach:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Sources:

Original Source(s)

“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

Related Content

Prime Editing Corrects GATA2 Deficiency in Patient Stem Cells

Retroperitoneal Spindle Cell Liposarcoma Presenting With Bowel Obstruction

Rising Endometrial Cancer Incidence: Clinical Priorities in Evaluation and Management